CTSO
Cytosorbents Corporation Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.090
Kõrge
$1.090
Madal
$1.090
Maht
0.01M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains CytoSorbents with a Buy and maintains $10 price target.
HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target
HC Wainwright & Co. analyst Sean Lee reiterates CytoSorbents with a Neutral and maintains $1 price target.
CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
D. Boral Capital Maintains Buy on CytoSorbents, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains CytoSorbents with a Buy and maintains $10 price target.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.